Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He may have sold his options but what i see is he then bought common stock Line 5 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
All that called for management change is what you thought you get? I have said several times on here that don,t be so gun ho on it we can end up with worst then before and it appears at this time we have.
Elis you might want to look up Nite history.There name has changed for a reason several times. They have been caught doing funny things and have been fined heavenly for it.
n 2002, Knight paid $1.5 million to settle regulatory charges of violations such as not respecting posted quotes. Knight neither admitted nor denied the allegations.[5] In 2004, the company paid a $79 million settlement to customers whom they had overcharged.[6] In 2008, Knight traded an average of 3.97 billion shares per day.[7] In 2011, the company was worth $1.5 billion and employed approximately 1450 people.[8]
2012 stock trading disruption
On August 1, 2012, Knight Capital caused a major stock market disruption leading to a large trading loss for the company. The incident happened due to a technician forgetting to copy the new Retail Liquidity Program (RLP) code to one of the eight SMARS computer servers, which was Knight's automated routing system for equity orders. RLP code repurposed a flag that was formerly used to activate the old function known as 'Power Peg'. Power Peg was designed to move stock prices higher and lower in order to verify the behavior of trading algorithms in a controlled environment.[12] Therefore, orders sent with the repurposed flag to the eighth server triggered the defective Power Peg code still present on that server.[13] When released into production, Knight's trading activities caused a major disruption in the prices of 148 companies listed at the New York Stock Exchange, thus, for example, shares of Wizzard Software Corporation went from $3.50 to $14.76. For the 212 incoming parent orders that were processed by the defective Power Peg code, Knight Capital sent millions of child orders, resulting in 4 million executions in 154 stocks for more than 397 million shares in approximately 45 minutes.[13] Knight Capital took a pre-tax loss of $440 million. This caused Knight Capital's stock price to collapse, sending shares lower by over 70% from before the announcement. The nature of the Knight Capital's unusual trading activity was described as a "technology breakdown".[14][15]
On Sunday, August 5 the company managed to raise around $400 million from half a dozen investors led by Jefferies in an attempt to stay in business after the trading error. Jefferies' CEO, Richard Handler and Executive Committee Chair Brian Friedman structured and led the rescue and Jefferies purchased $125 million of the $400 million investment and became Knight's largest shareholder.[16][17] The financing would be in the form of convertible securities, bonds that turn into equity in the company at a fixed price in the future.[18]
The incident was embarrassing for Knight CEO Thomas Joyce, who was an outspoken critic of Nasdaq's handling of Facebook's IPO.[19] On the same day the company's stock plunged 33 percent, to $3.39; by the next day 75 percent of Knight's equity value had been erased.[20]
So Dodd got rid of a million shares
I think i will be in the hundreds
Any R&D Company is on the cusp nothing earth shattering
News out pretty good read
Are we heading back down in the 2s "
40 million in the hole something has to give soon
Green Owner don,t discount him in what he is saying with the players involved it looks that way. I hope not but it very well could happen.
I be-leave that's what will happen first a reverse split to get the shares down and price up then sale.
Heading to the 4s by end of Friday ?
He now owns 3 million shares
Where did i say i resent having a new CEO . With the history of failures and CEO,s this company has had i,m just saying why bring some one on with this type of back ground news. I will give him a chance.
This needs to be cleared up quickly by the new CEO in this conference call
CEO with baggage hanging over them. I also have six figures in stock holdings
Just great
There are thousands of similar Medical Devices that the FDA can compare.
If there is why is this taking so long then. Why is the FDA asking for more
The fact that there is no track record for this device or any like it hence the word Novel means in lawyer speak there is no case studies to look at. Dose not surprise me but what I'm surprised about is that they did not see this coming.
Thats why i warned a time ago you don,t want investor bankers involved because nine times out of ten they take the best parts of company sell it off and investors are stuck holding the crap.
Right on GE Every one that screamed for a CEO change is not any better.
People are all ready Dead
I think he is talking about new highs being in the dollars not 99cents
So any thing new at the CC today
Now we know who was selling all the shares it was Hoyt
Are we getting ready for a price run ?
Medizone International Conference Call:Wednesday June 21, 2017 from 4:00 - 5:00 PM EST
Medizone International, Inc. (OTCQB: MZEI), the developer of AsepticSure®, today announced that the company will host a conference call on Wednesday June 21, 2017 from 4:00 - 5:00 PM EST to provide an update on global commercial operations and address questions from investors.
Call in details and presentation materials will be made available on the Company's website prior to the call (www.medizoneint.com).
A replay of the conference call will be available for seven days after the call. The conference call and replay are open to all interested parties.
Please submit questions to be addressed on the call to John Pentony, Investor Relations: j.pentony@medizoneint.com
Contact:
John Pentony
Investor and Media Relations
Medizone International, Inc.
T: 01 269-202-5020
Email: j.pentony@medizoneint.com
http://www.medizoneint.com
All this selling has been controlled so not to push the price down to far.
Reverse split coming ?
There is nothing we as investor can do about it. Pink sheets are the wild wild west. But do some back ground on NITE and who works with them and you will see the SEC has find them more then once.
NITE PRETTY MUCH STARTED THE PINK SHEETS AND OTHER MM GO TO THEM. THEY ALSO HAVE BEEN FINED BY THE SEC FOR TAPERING WITH STOCKS. THEY HAVE HAD SEVERAL NAME CHANGES THEY USE TO BE NITE CAPITOL
This is a real problem if true.
He implied that there have been no Trials because no hospital was willing to be the spokesperson for the new technology as being so amazing because then they will HAVE to continue to purchase and use the AS. So until a hospital is willing to pay the price
of long term use of AS, it might be difficult to find a supporting hospital.
I don't care about those company you cant compare us to them. They have market presents we don't' We have a better product but it dose not mean we will see that type of price. We can barely get out of the closet. So suggesting that we will see that price is false hope.
What we should be concerned about are the investment bankers they come in take the best part of the company and throw away the rest screwing stock holders in the processes just watch the movie wall street that will give you an idea of what they do.
Ed Marshall got us to this point yes he made some major mistakes but what ever it was for him to step a side dose not mean Esposito will do any better he has an great resume but he is only the interim one.
We have a long way to go yet before we see dollar land if we ever do.
Lets not start throwing number around like that.
There is no doubt that there will have to be some kind of reverse split.
You did not think he was going to step down with out protecting himself. That's why i said last year with the moves he was making he was getting ready to step a side i just did not think it would have taken so long.
WIV since you are an investment banker let here your thoughts on this.
NEWS OUT:
Medizone International Announces Agreement Retaining EMA Partners as Advisor and Investment Bank
KALAMAZOO, MICH. March 1,2017 - Medizone International, Inc. (OTCQB: MZEI), the developer of AsepticSure®, the only EPA cleared hospital room disinfection technology that combines ozone and hydrogen peroxide to achieve unprecedented kill rates of bacteria and viral pathogens, announced today that the Company has entered into a definitive agreement with EMA Partners retaining them as the Company's advisor for financing and investment banking matters.
In late 2016, AsepticSure was cleared by the U.S. Environmental Protection Agency for entry into the United States market. The Company has been preparing for entry into a significant market that has a growing need for effective technologies that are capable of breaking the hospital acquired infection cycle.
"We are very pleased to announce that Medizone International has reached an agreement to have EMA Partners serve as our advisor and investment bank. EMA Partners and its elite group of partners and life-science advisors have a remarkable track record of helping to create shareholder value in promising life-science companies," said David Esposito, Chairman and CEO of Medizone International. "As our team has completed several key milestones in the development of AsepticSure, we are preparing to scale our commercial operations in the United States and beyond. We look forward to EMA Partners helping us realize the full potential of our business."
"EMA Partners looks forward to working with the seasoned management team and board at Medizone to explore strategic options to scale the business and to develop strategic partnerships with a broad range of industry players," said Andy Raeder, founding partner of EMA Partners. "We believe the AsepticSure technology has the potential to significantly impact the large unmet need of reducing hospital acquired infections. In addition, we see a large number of other compelling areas where this technology could be deployed to increase value creation for the Company."
Medizone continues to execute on plans to increase manufacturing, technical service and support, and lead generation channels to secure initial U.S. customers for AsepticSure. The near term priority market is the United States while the Company continues to support sales and distribution channels in several other markets across the globe.
About Medizone International, Inc.
Founded initially in 1986 to develop treatments for lipid-enveloped viruses, Medizone International, Inc. shifted focus in 2007 in response to the increased prevalence and awareness of hospital acquired infections. The Company developed the AsepticSure system to combine anti-oxidant gases (O3 and H202) to produce unique free radicals (H2O3 known as trioxidane) with higher anti-oxidant potential than ozone or hydrogen peroxide alone. After securing broad IP protection for the use of trioxidane for both healthcare facility disinfecting systems and bioterrorism applications, the Company released its AsepticSure system for use in Canada, and several other global markets. With EPA approval in late 2016, the Company is now prepared to expand into the U.S. market.
Safe Harbor Statement
This press release contains forward looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, government regulation, manufacturing and marketing risks, adverse publicity risks, risks associated with our entry into the U.S. and other markets, expansion and operations. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
For press information on Medizone International, please contact:
John Pentony, Investor and Media Relations
Medizone International, Inc.
T: 01 269-202-5020
E: j.pentony@medizoneint.com
For more information, visit:
http://www.medizoneint.com
Email: operations@medizoneint.com
About EMA Partners, LLC
EMA is focused on assisting its clients with mergers, acquisitions, divestitures, intellectual property licensing and sales, recapitalizations, transition planning and other transactional-based services.
We apply a process and perspective well suited to middle market clients across all geographies. With a professional staff of advisors from a variety of business disciplines, we are able to provide the strategy, analytics, marketing and transactional work to meet our clients' goals across industry verticals. This expertise is reflected in the wide range of transactions EMA has handled, ranging from outright sale of traditional industrial companies to licensing of sophisticated pre-revenue intellectual property.
Our focus has always been on the middle market, and on understanding client companies' objectives and strengths, communicating those strengths to prospective buyers or partners, and structuring transactions in a manner that maximizes value for our clients.
For more information, visit www.emapartners.com. Securities -related services provided through Burch & Company, Inc., member FINRA/SIPC.
MEDIZONE INTERNATIONAL INC. | 269-202-5020| www.medizoneint.com
Told you guys last year when he was getting thing arranged that he was stepping down. Post 41536